jrnl6370

Publication Venue For

  • Glucocorticoid-induced osteoporosis update.  31:388-393. 2019
  • The promise and perils of 'Big Data': focus on spondyloarthritis.  31:355-361. 2019
  • Changing rates in fracture trends are temporally associated with declining testing and treatment: reality or ecologic fallacy?.  31:316-320. 2019
  • Opioid use in rheumatoid arthritis: trends, efficacy, safety, and best practices.  31:264-270. 2019
  • Patient perspectives in gout: A review.  31:159-166. 2019
  • The microbiota in pediatric rheumatic disease: Epiphenomenon or therapeutic target?.  28:537-543. 2016
  • Systemic sclerosis-associated fibrosis: An accelerated aging phenotype?.  27:571-576. 2015
  • Serum uric acid and the risk of hypertension and chronic kidney disease.  26:176-185. 2014
  • Risk of malignancy associated with biologic agents in pediatric rheumatic disease.  26:538-542. 2014
  • Study design considerations for a large simple trial of bisphosphonates.  25:517-523. 2013
  • New methods for determining comparative effectiveness in rheumatoid arthritis.  25:325-333. 2013
  • Newest clinical trial results with antitumor necrosis factor and nonantitumor necrosis factor biologics for rheumatoid arthritis.  25:384-390. 2013
  • Immune deficiency and autoimmunity.  24:515-521. 2012
  • Psoriatic juvenile idiopathic arthritis: A tale of two subgroups.  23:437-443. 2011
  • Obesity, bariatric surgery, and bone.  23:396-405. 2011
  • Risk factors for gout and prevention: A systematic review of the literature.  23:192-202. 2011
  • Current Opinion in Rheumatology: Editorial introductions.  22. 2010
  • Rheumatic manifestations of systemic disease: Sarcoidosis.  22:85-90. 2010
  • Innovative approaches to the therapy of fibrosis.  21:649-655. 2009
  • Adherence to osteoporosis treatments: Room for improvement.  21:356-362. 2009
  • Editorial introductions.  21. 2009
  • Association of infections and tuberculosis with antitumor necrosis factor alpha therapy.  20:320-326. 2008
  • Biologics and heart failure in rheumatoid arthritis: Are we any wiser?.  20:327-333. 2008
  • The epidemiology of glucocorticoid-associated adverse events.  20:131-137. 2008
  • Temporomandibular joint arthritis in juvenile idiopathic arthritis: The forgotten joint.  18:490-495. 2006
  • New insights into gout epidemiology.  18:199-203. 2006
  • Genetics of susceptibility and severity in systemic lupus erythematosus.  17:529-537. 2005
  • Nutritional considerations in osteoporosis.  15:476-480. 2003
  • Central nervous system mechanisms of pain in fibromyalgia and other musculoskeletal disorders: Behavioral and psychologic treatment approaches.  14:45-51. 2002
  • Metabolic bone disease.  14:404-405. 2002
  • Update on sarcoidosis.  11:83-87. 1999
  • Health services research.  9:118-125. 1997
  • Editorial overview: Rheumatoid arthritis.  8:201-202. 1996
  • Musculoskeletal syndromes associated with malignancies.  7:48-53. 1995
  • Rheumatoid arthritis: Editorial overview.  7:199-200. 1995
  • Systemic disorders with rheumatic manifestations: Editorial overview.  7:45-47. 1995
  • Glucocorticoids.  6:273-280. 1994
  • Murine models of autoimmune disease and Sjogren's syndrome.  5:557-569. 1993
  • Arthritis due to tuberculosis, fungal infections, and parasites.  4:516-519. 1992
  • Glucocorticoid therapy for rheumatic diseases.  4:325-331. 1992
  • Gout and hyperuricemia.  4:566-573. 1992
  • Infection as a cause of reactive arthritis, ankylosing spondylitis, and rheumatic fever.  4:534-542. 1992
  • Murine models of autoimmune disease.  4:621-629. 1992
  • Murine models of autoimmunity: T-cell and B-cell defects.  4:612-620. 1992
  • Infection as a cause of arthritis.  3:639-649. 1991
  • Mechanisms of action, dosage schedules, and side effects of steroid therapy.  3:373-379. 1991
  • Murine models for systemic lupus erythematosus and Sjogren's syndrome.  3:738-756. 1991
  • Animal models of systemic lupus erythematosus and Sjogren's syndrome.  2:740-748. 1990
  • Steroids.  2:510-516. 1990
  • Bacterial infections.  1:167-171. 1989
  • Glucocorticoids.  1:92-97. 1989
  • Immunopathology of rheumatoid arthritis.  1:8-14. 1989
  • Viral arthritis in humans.  1:185-193. 1989